| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| heart morphogenesis | 4 out of 54 genes, 7.4% | 4 out of 533 genes, 0.8% | 9.511169e-05 |
| muscle organ morphogenesis | 3 out of 54 genes, 5.6% | 3 out of 533 genes, 0.6% | 0.0009884156 |
| cardiac muscle tissue development | 3 out of 54 genes, 5.6% | 3 out of 533 genes, 0.6% | 0.0009884156 |
| cardiac muscle tissue morphogenesis | 3 out of 54 genes, 5.6% | 3 out of 533 genes, 0.6% | 0.0009884156 |
| muscle tissue morphogenesis | 3 out of 54 genes, 5.6% | 3 out of 533 genes, 0.6% | 0.0009884156 |
| muscle organ development | 4 out of 54 genes, 7.4% | 6 out of 533 genes, 1.1% | 0.001219264 |
| actin filament-based movement | 4 out of 54 genes, 7.4% | 6 out of 533 genes, 1.1% | 0.001219264 |
| cellular component assembly involved in morphogenesis | 4 out of 54 genes, 7.4% | 7 out of 533 genes, 1.3% | 0.002630649 |
| circulatory system process | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| heart process | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| blood circulation | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| myofibril assembly | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| actomyosin structure organization | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| actin-myosin filament sliding | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| heart contraction | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| actin-mediated cell contraction | 3 out of 54 genes, 5.6% | 4 out of 533 genes, 0.8% | 0.003668327 |
| organ morphogenesis | 5 out of 54 genes, 9.3% | 13 out of 533 genes, 2.4% | 0.006089799 |
| heart development | 4 out of 54 genes, 7.4% | 9 out of 533 genes, 1.7% | 0.00810142 |
| tissue morphogenesis | 4 out of 54 genes, 7.4% | 9 out of 533 genes, 1.7% | 0.00810142 |
| muscle system process | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| muscle contraction | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| striated muscle tissue development | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| muscle cell development | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| striated muscle cell development | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| muscle tissue development | 3 out of 54 genes, 5.6% | 5 out of 533 genes, 0.9% | 0.00851142 |
| cardiovascular system development | 5 out of 54 genes, 9.3% | 14 out of 533 genes, 2.6% | 0.008746269 |
| circulatory system development | 5 out of 54 genes, 9.3% | 14 out of 533 genes, 2.6% | 0.008746269 |
| striated muscle contraction | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| plasma membrane organization | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| regulation of blood pressure | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| skeletal myofibril assembly | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| skeletal muscle thin filament assembly | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiocyte differentiation | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiac myofibril assembly | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiac cell development | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiac muscle cell differentiation | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiac muscle cell development | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| cardiac muscle contraction | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| protein localization to plasma membrane | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| protein targeting to plasma membrane | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| establishment of protein localization to plasma membrane | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| establishment of protein localization to membrane | 2 out of 54 genes, 3.7% | 2 out of 533 genes, 0.4% | 0.01009324 |
| anatomical structure formation involved in morphogenesis | 6 out of 54 genes, 11.1% | 20 out of 533 genes, 3.8% | 0.01038553 |
| muscle structure development | 4 out of 54 genes, 7.4% | 11 out of 533 genes, 2.1% | 0.01816405 |
| tissue development | 5 out of 54 genes, 9.3% | 17 out of 533 genes, 3.2% | 0.02129119 |
| striated muscle cell differentiation | 3 out of 54 genes, 5.6% | 7 out of 533 genes, 1.3% | 0.02568327 |
| muscle filament sliding | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| negative regulation of cell migration | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| skeletal muscle fiber development | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| muscle fiber development | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| negative regulation of cellular component movement | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| protein localization to membrane | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| negative regulation of cell motility | 2 out of 54 genes, 3.7% | 3 out of 533 genes, 0.6% | 0.0283029 |
| anatomical structure morphogenesis | 8 out of 54 genes, 14.8% | 39 out of 533 genes, 7.3% | 0.033268 |
| actin filament-based process | 5 out of 54 genes, 9.3% | 19 out of 533 genes, 3.6% | 0.03414126 |
| antigen processing and presentation of peptide antigen via MHC class II | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| skeletal muscle tissue development | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| antigen processing and presentation of exogenous peptide antigen via MHC class II | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| negative regulation of locomotion | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| skeletal muscle organ development | 2 out of 54 genes, 3.7% | 4 out of 533 genes, 0.8% | 0.05293748 |
| muscle cell differentiation | 3 out of 54 genes, 5.6% | 9 out of 533 genes, 1.7% | 0.05320993 |
| actin cytoskeleton organization | 4 out of 54 genes, 7.4% | 15 out of 533 genes, 2.8% | 0.05519313 |
| system development | 9 out of 54 genes, 16.7% | 51 out of 533 genes, 9.6% | 0.0589204 |
| organ development | 6 out of 54 genes, 11.1% | 31 out of 533 genes, 5.8% | 0.0814463 |
| positive regulation of cytokine production | 2 out of 54 genes, 3.7% | 5 out of 533 genes, 0.9% | 0.08255485 |
| regulation of muscle contraction | 2 out of 54 genes, 3.7% | 5 out of 533 genes, 0.9% | 0.08255485 |
| actin filament organization | 2 out of 54 genes, 3.7% | 5 out of 533 genes, 0.9% | 0.08255485 |
| positive regulation of multicellular organismal process | 3 out of 54 genes, 5.6% | 11 out of 533 genes, 2.1% | 0.09034677 |
| cellular component morphogenesis | 5 out of 54 genes, 9.3% | 25 out of 533 genes, 4.7% | 0.09727128 |
| establishment of protein localization | 11 out of 54 genes, 20.4% | 73 out of 533 genes, 13.7% | 0.1010129 |
| anatomical structure development | 11 out of 54 genes, 20.4% | 74 out of 533 genes, 13.9% | 0.1092391 |
| response to reactive oxygen species | 2 out of 54 genes, 3.7% | 6 out of 533 genes, 1.1% | 0.1159305 |
| negative regulation of actin filament depolymerization | 2 out of 54 genes, 3.7% | 6 out of 533 genes, 1.1% | 0.1159305 |
| negative regulation of actin filament polymerization | 2 out of 54 genes, 3.7% | 6 out of 533 genes, 1.1% | 0.1159305 |
| actin filament capping | 2 out of 54 genes, 3.7% | 6 out of 533 genes, 1.1% | 0.1159305 |
| regulation of muscle system process | 2 out of 54 genes, 3.7% | 6 out of 533 genes, 1.1% | 0.1159305 |
| cellular component movement | 6 out of 54 genes, 11.1% | 35 out of 533 genes, 6.6% | 0.1305523 |
| system process | 4 out of 54 genes, 7.4% | 20 out of 533 genes, 3.8% | 0.1339153 |
| regulation of anatomical structure size | 3 out of 54 genes, 5.6% | 13 out of 533 genes, 2.4% | 0.1355588 |
| cytoskeleton organization | 5 out of 54 genes, 9.3% | 28 out of 533 genes, 5.3% | 0.1424037 |
| in utero embryonic development | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| regulation of immune effector process | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| lipid biosynthetic process | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| regulation of actin filament depolymerization | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| negative regulation of protein polymerization | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| negative regulation of protein complex disassembly | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| negative regulation of protein depolymerization | 2 out of 54 genes, 3.7% | 7 out of 533 genes, 1.3% | 0.1520294 |
| lipid metabolic process | 4 out of 54 genes, 7.4% | 21 out of 533 genes, 3.9% | 0.1534219 |
| organelle organization | 11 out of 54 genes, 20.4% | 80 out of 533 genes, 15.0% | 0.1667605 |
| protein transport | 10 out of 54 genes, 18.5% | 72 out of 533 genes, 13.5% | 0.1752329 |
| regulation of cell migration | 3 out of 54 genes, 5.6% | 15 out of 533 genes, 2.8% | 0.186964 |
| regulation of locomotion | 3 out of 54 genes, 5.6% | 15 out of 533 genes, 2.8% | 0.186964 |
| regulation of system process | 3 out of 54 genes, 5.6% | 15 out of 533 genes, 2.8% | 0.186964 |
| regulation of cellular response to stress | 3 out of 54 genes, 5.6% | 15 out of 533 genes, 2.8% | 0.186964 |
| regulation of cell motility | 3 out of 54 genes, 5.6% | 15 out of 533 genes, 2.8% | 0.186964 |
| blood vessel development | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| vasculature development | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| fatty acid metabolic process | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| response to oxidative stress | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| embryo development ending in birth or egg hatching | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| negative regulation of protein complex assembly | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| regulation of stress-activated MAPK cascade | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| growth | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| chordate embryonic development | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| negative regulation of cytoskeleton organization | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| regulation of stress-activated protein kinase signaling cascade | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| regulation of protein depolymerization | 2 out of 54 genes, 3.7% | 8 out of 533 genes, 1.5% | 0.1899812 |
| single-organism developmental process | 9 out of 54 genes, 16.7% | 65 out of 533 genes, 12.2% | 0.1965409 |
| protein localization | 11 out of 54 genes, 20.4% | 84 out of 533 genes, 15.8% | 0.2124174 |
| regulation of intracellular protein kinase cascade | 5 out of 54 genes, 9.3% | 32 out of 533 genes, 6.0% | 0.2141901 |
| RNA splicing, via transesterification reactions | 3 out of 54 genes, 5.6% | 16 out of 533 genes, 3.0% | 0.2143787 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3 out of 54 genes, 5.6% | 16 out of 533 genes, 3.0% | 0.2143787 |
| mRNA splicing, via spliceosome | 3 out of 54 genes, 5.6% | 16 out of 533 genes, 3.0% | 0.2143787 |
| regulation of cellular component movement | 3 out of 54 genes, 5.6% | 16 out of 533 genes, 3.0% | 0.2143787 |
| regulation of multicellular organismal process | 7 out of 54 genes, 13.0% | 49 out of 533 genes, 9.2% | 0.2157903 |
| small GTPase mediated signal transduction | 4 out of 54 genes, 7.4% | 24 out of 533 genes, 4.5% | 0.2176582 |
| response to external stimulus | 4 out of 54 genes, 7.4% | 24 out of 533 genes, 4.5% | 0.2176582 |
| negative regulation of organelle organization | 2 out of 54 genes, 3.7% | 9 out of 533 genes, 1.7% | 0.2290588 |
| cell projection assembly | 2 out of 54 genes, 3.7% | 9 out of 533 genes, 1.7% | 0.2290588 |
| regulation of actin filament polymerization | 2 out of 54 genes, 3.7% | 9 out of 533 genes, 1.7% | 0.2290588 |
| regulation of protein complex disassembly | 2 out of 54 genes, 3.7% | 9 out of 533 genes, 1.7% | 0.2290588 |
| apoptotic process | 3 out of 54 genes, 5.6% | 17 out of 533 genes, 3.2% | 0.2426192 |
| programmed cell death | 3 out of 54 genes, 5.6% | 17 out of 533 genes, 3.2% | 0.2426192 |
| single-multicellular organism process | 11 out of 54 genes, 20.4% | 88 out of 533 genes, 16.5% | 0.2630929 |
| RNA splicing | 4 out of 54 genes, 7.4% | 26 out of 533 genes, 4.9% | 0.2640821 |
| cellular developmental process | 8 out of 54 genes, 14.8% | 61 out of 533 genes, 11.4% | 0.266044 |
| antigen processing and presentation of exogenous peptide antigen | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| immune response | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| regulation of actin polymerization or depolymerization | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| positive regulation of organelle organization | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| antigen processing and presentation of exogenous antigen | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| regulation of cell morphogenesis | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| regulation of actin filament length | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| regulation of protein polymerization | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| regulation of multi-organism process | 2 out of 54 genes, 3.7% | 10 out of 533 genes, 1.9% | 0.2686583 |
| cell death | 3 out of 54 genes, 5.6% | 18 out of 533 genes, 3.4% | 0.2714616 |
| death | 3 out of 54 genes, 5.6% | 18 out of 533 genes, 3.4% | 0.2714616 |
| multicellular organismal development | 9 out of 54 genes, 16.7% | 71 out of 533 genes, 13.3% | 0.2808362 |
| cell projection organization | 4 out of 54 genes, 7.4% | 27 out of 533 genes, 5.1% | 0.2880204 |
| regulation of response to stress | 4 out of 54 genes, 7.4% | 27 out of 533 genes, 5.1% | 0.2880204 |
| regulation of cytokine production | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of nucleoside metabolic process | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| antigen processing and presentation | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of nucleotide catabolic process | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| monocarboxylic acid metabolic process | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of actin cytoskeleton organization | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of actin filament-based process | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of purine nucleotide catabolic process | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| antigen processing and presentation of peptide antigen | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| epithelium development | 2 out of 54 genes, 3.7% | 11 out of 533 genes, 2.1% | 0.3082831 |
| regulation of cellular component organization | 6 out of 54 genes, 11.1% | 46 out of 533 genes, 8.6% | 0.3174801 |
| cellular membrane organization | 3 out of 54 genes, 5.6% | 20 out of 533 genes, 3.8% | 0.330128 |
| membrane organization | 3 out of 54 genes, 5.6% | 20 out of 533 genes, 3.8% | 0.330128 |
| multicellular organismal process | 11 out of 54 genes, 20.4% | 93 out of 533 genes, 17.4% | 0.3319286 |
| cell differentiation | 7 out of 54 genes, 13.0% | 56 out of 533 genes, 10.5% | 0.3341892 |
| cell development | 4 out of 54 genes, 7.4% | 29 out of 533 genes, 5.4% | 0.3367804 |
| organic substance transport | 10 out of 54 genes, 18.5% | 84 out of 533 genes, 15.8% | 0.3372603 |
| developmental process | 11 out of 54 genes, 20.4% | 94 out of 533 genes, 17.6% | 0.3462412 |
| macromolecule localization | 11 out of 54 genes, 20.4% | 94 out of 533 genes, 17.6% | 0.3462412 |
| response to inorganic substance | 2 out of 54 genes, 3.7% | 12 out of 533 genes, 2.3% | 0.3475283 |
| regulation of cellular component size | 2 out of 54 genes, 3.7% | 12 out of 533 genes, 2.3% | 0.3475283 |
| positive regulation of MAPK cascade | 2 out of 54 genes, 3.7% | 12 out of 533 genes, 2.3% | 0.3475283 |
| negative regulation of cell differentiation | 2 out of 54 genes, 3.7% | 12 out of 533 genes, 2.3% | 0.3475283 |
| regulation of secretion | 2 out of 54 genes, 3.7% | 12 out of 533 genes, 2.3% | 0.3475283 |
| response to abiotic stimulus | 3 out of 54 genes, 5.6% | 21 out of 533 genes, 3.9% | 0.3595791 |
| positive regulation of intracellular protein kinase cascade | 3 out of 54 genes, 5.6% | 21 out of 533 genes, 3.9% | 0.3595791 |
| cell adhesion | 4 out of 54 genes, 7.4% | 30 out of 533 genes, 5.6% | 0.3613868 |
| biological adhesion | 4 out of 54 genes, 7.4% | 30 out of 533 genes, 5.6% | 0.3613868 |
| regulation of signaling | 8 out of 54 genes, 14.8% | 67 out of 533 genes, 12.6% | 0.3642644 |
| regulation of nucleotide metabolic process | 2 out of 54 genes, 3.7% | 13 out of 533 genes, 2.4% | 0.3860682 |
| regulation of cellular catabolic process | 2 out of 54 genes, 3.7% | 13 out of 533 genes, 2.4% | 0.3860682 |
| regulation of I-kappaB kinase/NF-kappaB cascade | 2 out of 54 genes, 3.7% | 13 out of 533 genes, 2.4% | 0.3860682 |
| regulation of purine nucleotide metabolic process | 2 out of 54 genes, 3.7% | 13 out of 533 genes, 2.4% | 0.3860682 |
| regulation of organelle organization | 3 out of 54 genes, 5.6% | 22 out of 533 genes, 4.1% | 0.3888878 |
| regulation of MAPK cascade | 3 out of 54 genes, 5.6% | 22 out of 533 genes, 4.1% | 0.3888878 |
| single-organism process | 36 out of 54 genes, 66.7% | 341 out of 533 genes, 64.0% | 0.3920389 |
| intracellular signal transduction | 6 out of 54 genes, 11.1% | 50 out of 533 genes, 9.4% | 0.3955767 |
| response to stimulus | 19 out of 54 genes, 35.2% | 175 out of 533 genes, 32.8% | 0.4019146 |
| cellular protein localization | 7 out of 54 genes, 13.0% | 60 out of 533 genes, 11.3% | 0.4065026 |
| cellular macromolecule localization | 7 out of 54 genes, 13.0% | 60 out of 533 genes, 11.3% | 0.4065026 |
| intracellular protein transport | 6 out of 54 genes, 11.1% | 51 out of 533 genes, 9.6% | 0.4152591 |
| regulation of multicellular organismal development | 3 out of 54 genes, 5.6% | 23 out of 533 genes, 4.3% | 0.4179098 |
| cellular lipid metabolic process | 2 out of 54 genes, 3.7% | 14 out of 533 genes, 2.6% | 0.4236446 |
| negative regulation of developmental process | 2 out of 54 genes, 3.7% | 14 out of 533 genes, 2.6% | 0.4236446 |
| regulation of phosphate metabolic process | 5 out of 54 genes, 9.3% | 42 out of 533 genes, 7.9% | 0.4246538 |
| regulation of phosphorus metabolic process | 5 out of 54 genes, 9.3% | 42 out of 533 genes, 7.9% | 0.4246538 |
| localization | 16 out of 54 genes, 29.6% | 148 out of 533 genes, 27.8% | 0.428405 |
| regulation of cell differentiation | 3 out of 54 genes, 5.6% | 24 out of 533 genes, 4.5% | 0.4465171 |
| DNA metabolic process | 4 out of 54 genes, 7.4% | 34 out of 533 genes, 6.4% | 0.4590747 |
| mRNA processing | 4 out of 54 genes, 7.4% | 34 out of 533 genes, 6.4% | 0.4590747 |
| cell migration | 2 out of 54 genes, 3.7% | 15 out of 533 genes, 2.8% | 0.460057 |
| regulation of protein complex assembly | 2 out of 54 genes, 3.7% | 15 out of 533 genes, 2.8% | 0.460057 |
| negative regulation of cellular component organization | 2 out of 54 genes, 3.7% | 15 out of 533 genes, 2.8% | 0.460057 |
| establishment of localization | 14 out of 54 genes, 25.9% | 133 out of 533 genes, 25.0% | 0.487742 |
| cellular response to stimulus | 14 out of 54 genes, 25.9% | 133 out of 533 genes, 25.0% | 0.487742 |
| embryo development | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| chromatin modification | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| regulation of anatomical structure morphogenesis | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| cell motility | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| regulation of cytoskeleton organization | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| localization of cell | 2 out of 54 genes, 3.7% | 16 out of 533 genes, 3.0% | 0.4951539 |
| positive regulation of metabolic process | 8 out of 54 genes, 14.8% | 75 out of 533 genes, 14.1% | 0.5001647 |
| regulation of immune system process | 3 out of 54 genes, 5.6% | 26 out of 533 genes, 4.9% | 0.5020568 |
| positive regulation of protein metabolic process | 4 out of 54 genes, 7.4% | 36 out of 533 genes, 6.8% | 0.5063344 |
| regulation of cell communication | 7 out of 54 genes, 13.0% | 66 out of 533 genes, 12.4% | 0.5146794 |
| positive regulation of biological process | 12 out of 54 genes, 22.2% | 116 out of 533 genes, 21.8% | 0.5244505 |
| response to oxygen-containing compound | 3 out of 54 genes, 5.6% | 27 out of 533 genes, 5.1% | 0.5288114 |
| transcription, DNA-dependent | 2 out of 54 genes, 3.7% | 17 out of 533 genes, 3.2% | 0.5288253 |
| chemotaxis | 2 out of 54 genes, 3.7% | 17 out of 533 genes, 3.2% | 0.5288253 |
| taxis | 2 out of 54 genes, 3.7% | 17 out of 533 genes, 3.2% | 0.5288253 |
| negative regulation of apoptotic process | 2 out of 54 genes, 3.7% | 17 out of 533 genes, 3.2% | 0.5288253 |
| regulation of cellular component biogenesis | 2 out of 54 genes, 3.7% | 17 out of 533 genes, 3.2% | 0.5288253 |
| regulation of developmental process | 4 out of 54 genes, 7.4% | 37 out of 533 genes, 6.9% | 0.5293313 |
| cell communication | 11 out of 54 genes, 20.4% | 107 out of 533 genes, 20.1% | 0.5371443 |
| regulation of signal transduction | 6 out of 54 genes, 11.1% | 58 out of 533 genes, 10.9% | 0.5497093 |
| positive regulation of protein modification process | 3 out of 54 genes, 5.6% | 28 out of 533 genes, 5.3% | 0.554794 |
| locomotion | 3 out of 54 genes, 5.6% | 28 out of 533 genes, 5.3% | 0.554794 |
| regulation of phosphorylation | 3 out of 54 genes, 5.6% | 28 out of 533 genes, 5.3% | 0.554794 |
| protein ubiquitination | 2 out of 54 genes, 3.7% | 18 out of 533 genes, 3.4% | 0.5609957 |
| negative regulation of programmed cell death | 2 out of 54 genes, 3.7% | 18 out of 533 genes, 3.4% | 0.5609957 |
| positive regulation of cellular component organization | 2 out of 54 genes, 3.7% | 18 out of 533 genes, 3.4% | 0.5609957 |
| negative regulation of cell death | 2 out of 54 genes, 3.7% | 18 out of 533 genes, 3.4% | 0.5609957 |
| signal transduction | 10 out of 54 genes, 18.5% | 99 out of 533 genes, 18.6% | 0.5655271 |
| cellular component organization | 17 out of 54 genes, 31.5% | 169 out of 533 genes, 31.7% | 0.5702288 |
| organic acid metabolic process | 3 out of 54 genes, 5.6% | 29 out of 533 genes, 5.4% | 0.5799494 |
| carboxylic acid metabolic process | 3 out of 54 genes, 5.6% | 29 out of 533 genes, 5.4% | 0.5799494 |
| oxoacid metabolic process | 3 out of 54 genes, 5.6% | 29 out of 533 genes, 5.4% | 0.5799494 |
| positive regulation of macromolecule metabolic process | 7 out of 54 genes, 13.0% | 70 out of 533 genes, 13.1% | 0.5834629 |
| positive regulation of protein phosphorylation | 2 out of 54 genes, 3.7% | 19 out of 533 genes, 3.6% | 0.5916192 |
| regulation of catabolic process | 2 out of 54 genes, 3.7% | 19 out of 533 genes, 3.6% | 0.5916192 |
| protein modification by small protein conjugation | 2 out of 54 genes, 3.7% | 19 out of 533 genes, 3.6% | 0.5916192 |
| regulation of response to stimulus | 7 out of 54 genes, 13.0% | 71 out of 533 genes, 13.3% | 0.5999904 |
| transport | 13 out of 54 genes, 24.1% | 132 out of 533 genes, 24.8% | 0.6061129 |
| single-organism cellular process | 32 out of 54 genes, 59.3% | 320 out of 533 genes, 60.0% | 0.6089856 |
| cell part morphogenesis | 2 out of 54 genes, 3.7% | 20 out of 533 genes, 3.8% | 0.6206738 |
| positive regulation of phosphorylation | 2 out of 54 genes, 3.7% | 20 out of 533 genes, 3.8% | 0.6206738 |
| cell projection morphogenesis | 2 out of 54 genes, 3.7% | 20 out of 533 genes, 3.8% | 0.6206738 |
| signaling | 10 out of 54 genes, 18.5% | 103 out of 533 genes, 19.3% | 0.6227039 |
| single organism signaling | 10 out of 54 genes, 18.5% | 103 out of 533 genes, 19.3% | 0.6227039 |
| regulation of localization | 5 out of 54 genes, 9.3% | 52 out of 533 genes, 9.8% | 0.6270093 |
| positive regulation of transcription from RNA polymerase II promoter | 2 out of 54 genes, 3.7% | 21 out of 533 genes, 3.9% | 0.6481574 |
| oxidation-reduction process | 2 out of 54 genes, 3.7% | 21 out of 533 genes, 3.9% | 0.6481574 |
| positive regulation of signal transduction | 3 out of 54 genes, 5.6% | 32 out of 533 genes, 6.0% | 0.6500698 |
| positive regulation of cell communication | 3 out of 54 genes, 5.6% | 32 out of 533 genes, 6.0% | 0.6500698 |
| positive regulation of signaling | 3 out of 54 genes, 5.6% | 32 out of 533 genes, 6.0% | 0.6500698 |
| positive regulation of cellular protein metabolic process | 3 out of 54 genes, 5.6% | 32 out of 533 genes, 6.0% | 0.6500698 |
| positive regulation of macromolecule biosynthetic process | 4 out of 54 genes, 7.4% | 43 out of 533 genes, 8.1% | 0.6555761 |
| positive regulation of cellular process | 10 out of 54 genes, 18.5% | 106 out of 533 genes, 19.9% | 0.6632368 |
| cell morphogenesis | 2 out of 54 genes, 3.7% | 22 out of 533 genes, 4.1% | 0.6740844 |
| chromatin organization | 2 out of 54 genes, 3.7% | 22 out of 533 genes, 4.1% | 0.6740844 |
| positive regulation of phosphorus metabolic process | 2 out of 54 genes, 3.7% | 22 out of 533 genes, 4.1% | 0.6740844 |
| positive regulation of phosphate metabolic process | 2 out of 54 genes, 3.7% | 22 out of 533 genes, 4.1% | 0.6740844 |
| cellular component organization or biogenesis | 17 out of 54 genes, 31.5% | 180 out of 533 genes, 33.8% | 0.6973829 |
| protein modification by small protein conjugation or removal | 2 out of 54 genes, 3.7% | 23 out of 533 genes, 4.3% | 0.6984819 |
| intracellular transport | 7 out of 54 genes, 13.0% | 78 out of 533 genes, 14.6% | 0.7060773 |
| positive regulation of cellular biosynthetic process | 4 out of 54 genes, 7.4% | 46 out of 533 genes, 8.6% | 0.7099137 |
| regulation of transcription from RNA polymerase II promoter | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| regulation of cell death | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| vesicle-mediated transport | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| regulation of protein modification process | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| regulation of apoptotic process | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| regulation of programmed cell death | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| carbohydrate derivative catabolic process | 3 out of 54 genes, 5.6% | 35 out of 533 genes, 6.6% | 0.7117659 |
| positive regulation of biosynthetic process | 4 out of 54 genes, 7.4% | 47 out of 533 genes, 8.8% | 0.7266361 |
| positive regulation of cellular metabolic process | 6 out of 54 genes, 11.1% | 69 out of 533 genes, 12.9% | 0.7292201 |
| nervous system development | 3 out of 54 genes, 5.6% | 36 out of 533 genes, 6.8% | 0.7304415 |
| positive regulation of gene expression | 3 out of 54 genes, 5.6% | 36 out of 533 genes, 6.8% | 0.7304415 |
| regulation of transport | 3 out of 54 genes, 5.6% | 36 out of 533 genes, 6.8% | 0.7304415 |
| cellular localization | 8 out of 54 genes, 14.8% | 91 out of 533 genes, 17.1% | 0.7374995 |
| regulation of protein phosphorylation | 2 out of 54 genes, 3.7% | 25 out of 533 genes, 4.7% | 0.7428478 |
| carbohydrate metabolic process | 2 out of 54 genes, 3.7% | 25 out of 533 genes, 4.7% | 0.7428478 |
| response to DNA damage stimulus | 2 out of 54 genes, 3.7% | 25 out of 533 genes, 4.7% | 0.7428478 |
| positive regulation of response to stimulus | 3 out of 54 genes, 5.6% | 37 out of 533 genes, 6.9% | 0.7481865 |
| regulation of biological quality | 6 out of 54 genes, 11.1% | 71 out of 533 genes, 13.3% | 0.7560751 |
| RNA processing | 4 out of 54 genes, 7.4% | 49 out of 533 genes, 9.2% | 0.7579918 |
| establishment of localization in cell | 7 out of 54 genes, 13.0% | 82 out of 533 genes, 15.4% | 0.7581379 |
| nucleic acid metabolic process | 10 out of 54 genes, 18.5% | 114 out of 533 genes, 21.4% | 0.7592158 |
| protein targeting to membrane | 2 out of 54 genes, 3.7% | 26 out of 533 genes, 4.9% | 0.7629137 |
| regulation of hydrolase activity | 2 out of 54 genes, 3.7% | 26 out of 533 genes, 4.9% | 0.7629137 |
| immune system process | 3 out of 54 genes, 5.6% | 38 out of 533 genes, 7.1% | 0.7650167 |
| positive regulation of RNA metabolic process | 3 out of 54 genes, 5.6% | 38 out of 533 genes, 7.1% | 0.7650167 |
| response to chemical stimulus | 6 out of 54 genes, 11.1% | 72 out of 533 genes, 13.5% | 0.7687904 |
| regulation of protein metabolic process | 5 out of 54 genes, 9.3% | 61 out of 533 genes, 11.4% | 0.7692781 |
| protein complex subunit organization | 5 out of 54 genes, 9.3% | 61 out of 533 genes, 11.4% | 0.7692781 |
| single-organism transport | 8 out of 54 genes, 14.8% | 94 out of 533 genes, 17.6% | 0.772679 |
| protein targeting | 3 out of 54 genes, 5.6% | 39 out of 533 genes, 7.3% | 0.7809515 |
| neurogenesis | 2 out of 54 genes, 3.7% | 27 out of 533 genes, 5.1% | 0.7816419 |
| generation of neurons | 2 out of 54 genes, 3.7% | 27 out of 533 genes, 5.1% | 0.7816419 |
| chromosome organization | 2 out of 54 genes, 3.7% | 27 out of 533 genes, 5.1% | 0.7816419 |
| regulation of cellular process | 23 out of 54 genes, 42.6% | 249 out of 533 genes, 46.7% | 0.7832508 |
| regulation of cellular metabolic process | 13 out of 54 genes, 24.1% | 148 out of 533 genes, 27.8% | 0.7858714 |
| regulation of cellular protein metabolic process | 4 out of 54 genes, 7.4% | 51 out of 533 genes, 9.6% | 0.7866013 |
| biological regulation | 26 out of 54 genes, 48.1% | 279 out of 533 genes, 52.3% | 0.7868054 |
| cellular component assembly | 6 out of 54 genes, 11.1% | 74 out of 533 genes, 13.9% | 0.7928021 |
| cellular response to stress | 3 out of 54 genes, 5.6% | 40 out of 533 genes, 7.5% | 0.7960137 |
| regulation of primary metabolic process | 13 out of 54 genes, 24.1% | 150 out of 533 genes, 28.1% | 0.8039495 |
| response to stress | 6 out of 54 genes, 11.1% | 76 out of 533 genes, 14.3% | 0.8149464 |
| protein complex assembly | 2 out of 54 genes, 3.7% | 29 out of 533 genes, 5.4% | 0.8153245 |
| proteolysis | 3 out of 54 genes, 5.6% | 42 out of 533 genes, 7.9% | 0.823623 |
| positive regulation of nucleobase-containing compound metabolic process | 3 out of 54 genes, 5.6% | 42 out of 533 genes, 7.9% | 0.823623 |
| RNA metabolic process | 7 out of 54 genes, 13.0% | 88 out of 533 genes, 16.5% | 0.8238421 |
| negative regulation of cellular process | 8 out of 54 genes, 14.8% | 99 out of 533 genes, 18.6% | 0.8239002 |
| mRNA metabolic process | 5 out of 54 genes, 9.3% | 66 out of 533 genes, 12.4% | 0.8290102 |
| cellular macromolecular complex assembly | 2 out of 54 genes, 3.7% | 30 out of 533 genes, 5.6% | 0.8304024 |
| protein complex biogenesis | 2 out of 54 genes, 3.7% | 30 out of 533 genes, 5.6% | 0.8304024 |
| cellular process | 44 out of 54 genes, 81.5% | 453 out of 533 genes, 85.0% | 0.8332395 |
| positive regulation of molecular function | 3 out of 54 genes, 5.6% | 43 out of 533 genes, 8.1% | 0.8362266 |
| negative regulation of cellular biosynthetic process | 2 out of 54 genes, 3.7% | 31 out of 533 genes, 5.8% | 0.8443877 |
| positive regulation of transcription, DNA-dependent | 2 out of 54 genes, 3.7% | 31 out of 533 genes, 5.8% | 0.8443877 |
| negative regulation of cellular macromolecule biosynthetic process | 2 out of 54 genes, 3.7% | 31 out of 533 genes, 5.8% | 0.8443877 |
| regulation of biological process | 24 out of 54 genes, 44.4% | 267 out of 533 genes, 50.1% | 0.8459925 |
| cell surface receptor signaling pathway | 4 out of 54 genes, 7.4% | 56 out of 533 genes, 10.5% | 0.846729 |
| positive regulation of nitrogen compound metabolic process | 3 out of 54 genes, 5.6% | 44 out of 533 genes, 8.3% | 0.8480691 |
| single-organism metabolic process | 9 out of 54 genes, 16.7% | 113 out of 533 genes, 21.2% | 0.8505035 |
| negative regulation of macromolecule biosynthetic process | 2 out of 54 genes, 3.7% | 32 out of 533 genes, 6.0% | 0.8573422 |
| regulation of macromolecule biosynthetic process | 8 out of 54 genes, 14.8% | 103 out of 533 genes, 19.3% | 0.8583754 |
| purine nucleoside catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| nucleoside triphosphate catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| purine nucleoside triphosphate catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| nucleoside catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| ribonucleoside triphosphate catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| purine ribonucleoside triphosphate catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| negative regulation of biosynthetic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| negative regulation of gene expression | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| ribonucleoside catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| purine ribonucleoside catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| glycosyl compound catabolic process | 2 out of 54 genes, 3.7% | 33 out of 533 genes, 6.2% | 0.8693267 |
| regulation of transcription, DNA-dependent | 6 out of 54 genes, 11.1% | 82 out of 533 genes, 15.4% | 0.8707223 |
| macromolecular complex subunit organization | 6 out of 54 genes, 11.1% | 82 out of 533 genes, 15.4% | 0.8707223 |
| regulation of cellular biosynthetic process | 8 out of 54 genes, 14.8% | 105 out of 533 genes, 19.7% | 0.873556 |
| purine nucleotide catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| purine ribonucleotide catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| nucleotide catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| ribonucleotide catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| positive regulation of catalytic activity | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| organophosphate catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| purine-containing compound catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| nucleoside phosphate catabolic process | 2 out of 54 genes, 3.7% | 34 out of 533 genes, 6.4% | 0.8804003 |
| regulation of RNA biosynthetic process | 6 out of 54 genes, 11.1% | 84 out of 533 genes, 15.8% | 0.8860133 |
| negative regulation of biological process | 8 out of 54 genes, 14.8% | 107 out of 533 genes, 20.1% | 0.8874384 |
| cellular response to chemical stimulus | 3 out of 54 genes, 5.6% | 48 out of 533 genes, 9.0% | 0.8884551 |
| regulation of biosynthetic process | 8 out of 54 genes, 14.8% | 108 out of 533 genes, 20.3% | 0.8939123 |
| macromolecular complex assembly | 3 out of 54 genes, 5.6% | 50 out of 533 genes, 9.4% | 0.9048994 |
| nucleobase-containing compound metabolic process | 13 out of 54 genes, 24.1% | 165 out of 533 genes, 31.0% | 0.9070824 |
| regulation of cellular macromolecule biosynthetic process | 7 out of 54 genes, 13.0% | 99 out of 533 genes, 18.6% | 0.9083734 |
| RNA biosynthetic process | 2 out of 54 genes, 3.7% | 37 out of 533 genes, 6.9% | 0.9087204 |
| organic cyclic compound metabolic process | 14 out of 54 genes, 25.9% | 176 out of 533 genes, 33.0% | 0.9090003 |
| regulation of nucleobase-containing compound metabolic process | 8 out of 54 genes, 14.8% | 111 out of 533 genes, 20.8% | 0.9115647 |
| regulation of metabolic process | 13 out of 54 genes, 24.1% | 166 out of 533 genes, 31.1% | 0.9120647 |
| nucleoside phosphate metabolic process | 3 out of 54 genes, 5.6% | 51 out of 533 genes, 9.6% | 0.912293 |
| nucleotide metabolic process | 3 out of 54 genes, 5.6% | 51 out of 533 genes, 9.6% | 0.912293 |
| carbohydrate derivative metabolic process | 3 out of 54 genes, 5.6% | 51 out of 533 genes, 9.6% | 0.912293 |
| multi-organism reproductive process | 2 out of 54 genes, 3.7% | 38 out of 533 genes, 7.1% | 0.916704 |
| cellular component biogenesis | 6 out of 54 genes, 11.1% | 89 out of 533 genes, 16.7% | 0.9178862 |
| regulation of catalytic activity | 3 out of 54 genes, 5.6% | 52 out of 533 genes, 9.8% | 0.9191742 |
| regulation of macromolecule metabolic process | 11 out of 54 genes, 20.4% | 146 out of 533 genes, 27.4% | 0.9197155 |
| purine nucleoside triphosphate metabolic process | 2 out of 54 genes, 3.7% | 39 out of 533 genes, 7.3% | 0.9240419 |
| purine ribonucleoside triphosphate metabolic process | 2 out of 54 genes, 3.7% | 39 out of 533 genes, 7.3% | 0.9240419 |
| regulation of cell proliferation | 2 out of 54 genes, 3.7% | 39 out of 533 genes, 7.3% | 0.9240419 |
| cellular response to organic substance | 2 out of 54 genes, 3.7% | 39 out of 533 genes, 7.3% | 0.9240419 |
| response to organic substance | 3 out of 54 genes, 5.6% | 53 out of 533 genes, 9.9% | 0.9255718 |
| organophosphate metabolic process | 3 out of 54 genes, 5.6% | 53 out of 533 genes, 9.9% | 0.9255718 |
| cellular aromatic compound metabolic process | 13 out of 54 genes, 24.1% | 169 out of 533 genes, 31.7% | 0.9257623 |
| regulation of molecular function | 4 out of 54 genes, 7.4% | 66 out of 533 genes, 12.4% | 0.9258241 |
| heterocycle metabolic process | 13 out of 54 genes, 24.1% | 170 out of 533 genes, 31.9% | 0.9299299 |
| ribonucleoside triphosphate metabolic process | 2 out of 54 genes, 3.7% | 40 out of 533 genes, 7.5% | 0.9307803 |
| purine nucleoside metabolic process | 2 out of 54 genes, 3.7% | 40 out of 533 genes, 7.5% | 0.9307803 |
| purine ribonucleoside metabolic process | 2 out of 54 genes, 3.7% | 40 out of 533 genes, 7.5% | 0.9307803 |
| organonitrogen compound catabolic process | 2 out of 54 genes, 3.7% | 40 out of 533 genes, 7.5% | 0.9307803 |
| regulation of nitrogen compound metabolic process | 8 out of 54 genes, 14.8% | 115 out of 533 genes, 21.6% | 0.9313012 |
| multi-organism process | 3 out of 54 genes, 5.6% | 54 out of 533 genes, 10.1% | 0.9315139 |
| regulation of RNA metabolic process | 6 out of 54 genes, 11.1% | 92 out of 533 genes, 17.3% | 0.9331481 |
| regulation of gene expression | 8 out of 54 genes, 14.8% | 116 out of 533 genes, 21.8% | 0.9356166 |
| nucleoside triphosphate metabolic process | 2 out of 54 genes, 3.7% | 41 out of 533 genes, 7.7% | 0.9369624 |
| nucleobase-containing small molecule metabolic process | 3 out of 54 genes, 5.6% | 55 out of 533 genes, 10.3% | 0.9370276 |
| organonitrogen compound metabolic process | 4 out of 54 genes, 7.4% | 69 out of 533 genes, 12.9% | 0.9412317 |
| ribonucleoside metabolic process | 2 out of 54 genes, 3.7% | 42 out of 533 genes, 7.9% | 0.9426294 |
| cellular nitrogen compound metabolic process | 13 out of 54 genes, 24.1% | 174 out of 533 genes, 32.6% | 0.9447571 |
| small molecule metabolic process | 6 out of 54 genes, 11.1% | 95 out of 533 genes, 17.8% | 0.9459222 |
| purine nucleotide metabolic process | 2 out of 54 genes, 3.7% | 43 out of 533 genes, 8.1% | 0.9478198 |
| nucleoside metabolic process | 2 out of 54 genes, 3.7% | 43 out of 533 genes, 8.1% | 0.9478198 |
| purine ribonucleotide metabolic process | 2 out of 54 genes, 3.7% | 43 out of 533 genes, 8.1% | 0.9478198 |
| purine-containing compound metabolic process | 2 out of 54 genes, 3.7% | 43 out of 533 genes, 8.1% | 0.9478198 |
| glycosyl compound metabolic process | 2 out of 54 genes, 3.7% | 43 out of 533 genes, 8.1% | 0.9478198 |
| ribonucleotide metabolic process | 2 out of 54 genes, 3.7% | 44 out of 533 genes, 8.3% | 0.9525698 |
| ribose phosphate metabolic process | 2 out of 54 genes, 3.7% | 44 out of 533 genes, 8.3% | 0.9525698 |
| negative regulation of cellular metabolic process | 2 out of 54 genes, 3.7% | 46 out of 533 genes, 8.6% | 0.9608824 |
| nitrogen compound metabolic process | 13 out of 54 genes, 24.1% | 181 out of 533 genes, 34.0% | 0.9644824 |
| organic cyclic compound biosynthetic process | 3 out of 54 genes, 5.6% | 62 out of 533 genes, 11.6% | 0.9656796 |
| catabolic process | 7 out of 54 genes, 13.0% | 115 out of 533 genes, 21.6% | 0.9696807 |
| reproductive process | 2 out of 54 genes, 3.7% | 50 out of 533 genes, 9.4% | 0.9735748 |
| macromolecule biosynthetic process | 4 out of 54 genes, 7.4% | 79 out of 533 genes, 14.8% | 0.9741573 |
| cellular macromolecule biosynthetic process | 4 out of 54 genes, 7.4% | 79 out of 533 genes, 14.8% | 0.9741573 |
| cellular protein modification process | 3 out of 54 genes, 5.6% | 66 out of 533 genes, 12.4% | 0.9760841 |
| nucleobase-containing compound catabolic process | 3 out of 54 genes, 5.6% | 66 out of 533 genes, 12.4% | 0.9760841 |
| protein modification process | 3 out of 54 genes, 5.6% | 66 out of 533 genes, 12.4% | 0.9760841 |
| aromatic compound catabolic process | 3 out of 54 genes, 5.6% | 67 out of 533 genes, 12.6% | 0.9781828 |
| gene expression | 6 out of 54 genes, 11.1% | 107 out of 533 genes, 20.1% | 0.9782273 |
| negative regulation of macromolecule metabolic process | 2 out of 54 genes, 3.7% | 52 out of 533 genes, 9.8% | 0.9783522 |
| negative regulation of metabolic process | 2 out of 54 genes, 3.7% | 53 out of 533 genes, 9.9% | 0.980422 |
| macromolecule modification | 3 out of 54 genes, 5.6% | 69 out of 533 genes, 12.9% | 0.9818764 |
| cellular nitrogen compound catabolic process | 3 out of 54 genes, 5.6% | 70 out of 533 genes, 13.1% | 0.9834963 |
| heterocycle catabolic process | 3 out of 54 genes, 5.6% | 70 out of 533 genes, 13.1% | 0.9834963 |
| organic cyclic compound catabolic process | 3 out of 54 genes, 5.6% | 70 out of 533 genes, 13.1% | 0.9834963 |
| reproduction | 2 out of 54 genes, 3.7% | 55 out of 533 genes, 10.3% | 0.9840116 |
| nucleobase-containing compound biosynthetic process | 2 out of 54 genes, 3.7% | 55 out of 533 genes, 10.3% | 0.9840116 |
| organic substance catabolic process | 6 out of 54 genes, 11.1% | 111 out of 533 genes, 20.8% | 0.9842568 |
| cellular biosynthetic process | 6 out of 54 genes, 11.1% | 114 out of 533 genes, 21.4% | 0.9877371 |
| aromatic compound biosynthetic process | 2 out of 54 genes, 3.7% | 58 out of 533 genes, 10.9% | 0.988245 |
| macromolecule metabolic process | 16 out of 54 genes, 29.6% | 229 out of 533 genes, 43.0% | 0.9883399 |
| heterocycle biosynthetic process | 2 out of 54 genes, 3.7% | 59 out of 533 genes, 11.1% | 0.9894008 |
| cellular macromolecule catabolic process | 2 out of 54 genes, 3.7% | 59 out of 533 genes, 11.1% | 0.9894008 |
| cellular nitrogen compound biosynthetic process | 2 out of 54 genes, 3.7% | 59 out of 533 genes, 11.1% | 0.9894008 |
| phosphorus metabolic process | 3 out of 54 genes, 5.6% | 75 out of 533 genes, 14.1% | 0.9897546 |
| phosphate-containing compound metabolic process | 3 out of 54 genes, 5.6% | 75 out of 533 genes, 14.1% | 0.9897546 |
| cellular catabolic process | 5 out of 54 genes, 9.3% | 104 out of 533 genes, 19.5% | 0.9905735 |
| organic substance biosynthetic process | 6 out of 54 genes, 11.1% | 118 out of 533 genes, 22.1% | 0.9912874 |
| primary metabolic process | 23 out of 54 genes, 42.6% | 304 out of 533 genes, 57.0% | 0.9916939 |
| biosynthetic process | 6 out of 54 genes, 11.1% | 120 out of 533 genes, 22.5% | 0.9926831 |
| macromolecule catabolic process | 2 out of 54 genes, 3.7% | 63 out of 533 genes, 11.8% | 0.9930274 |
| cellular macromolecule metabolic process | 14 out of 54 genes, 25.9% | 216 out of 533 genes, 40.5% | 0.993944 |
| organic substance metabolic process | 23 out of 54 genes, 42.6% | 311 out of 533 genes, 58.3% | 0.9954028 |
| metabolic process | 24 out of 54 genes, 44.4% | 321 out of 533 genes, 60.2% | 0.9955883 |
| cellular metabolic process | 21 out of 54 genes, 38.9% | 297 out of 533 genes, 55.7% | 0.9971564 |
| protein metabolic process | 7 out of 54 genes, 13.0% | 158 out of 533 genes, 29.6% | 0.9993124 |
| cellular protein metabolic process | 5 out of 54 genes, 9.3% | 143 out of 533 genes, 26.8% | 0.9998093 |
| Gene Ontology term | Genes annotated to the term |
|---|
| heart morphogenesis | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000002381 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000006558, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| organ morphogenesis | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008799, ENSAPLP00000002381 |
| heart development | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| tissue morphogenesis | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiovascular system development | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| plasma membrane organization | ENSAPLP00000015416, ENSAPLP00000013090 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| skeletal muscle thin filament assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiocyte differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| protein localization to plasma membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| protein targeting to plasma membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| establishment of protein localization to plasma membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| establishment of protein localization to membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000006558, ENSAPLP00000002381 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000002381 |
| tissue development | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000002381 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| negative regulation of cell migration | ENSAPLP00000003219, ENSAPLP00000014519 |
| skeletal muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| negative regulation of cellular component movement | ENSAPLP00000003219, ENSAPLP00000014519 |
| protein localization to membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| negative regulation of cell motility | ENSAPLP00000003219, ENSAPLP00000014519 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000002381, ENSAPLP00000014519 |
| antigen processing and presentation of peptide antigen via MHC class II | ENSAPLP00000015838, ENSAPLP00000008799 |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | ENSAPLP00000015838, ENSAPLP00000008799 |
| skeletal muscle tissue development | ENSAPLP00000003657, ENSAPLP00000002381 |
| antigen processing and presentation of exogenous peptide antigen via MHC class II | ENSAPLP00000015838, ENSAPLP00000008799 |
| negative regulation of locomotion | ENSAPLP00000003219, ENSAPLP00000014519 |
| skeletal muscle organ development | ENSAPLP00000003657, ENSAPLP00000002381 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381, ENSAPLP00000014519 |
| system development | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| organ development | ENSAPLP00000015416, ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008799, ENSAPLP00000002381 |
| positive regulation of cytokine production | ENSAPLP00000015838, ENSAPLP00000004050 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000013090 |
| actin filament organization | ENSAPLP00000003657, ENSAPLP00000002381 |
| positive regulation of multicellular organismal process | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000006558, ENSAPLP00000013090, ENSAPLP00000002381 |
| establishment of protein localization | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000014519 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| response to reactive oxygen species | ENSAPLP00000007174, ENSAPLP00000003219 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000013090 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000002381 |
| system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000002381 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000002381, ENSAPLP00000014519 |
| in utero embryonic development | ENSAPLP00000015416, ENSAPLP00000003219 |
| regulation of immune effector process | ENSAPLP00000015838, ENSAPLP00000008799 |
| lipid biosynthetic process | ENSAPLP00000015838, ENSAPLP00000010639 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| lipid metabolic process | ENSAPLP00000007174, ENSAPLP00000015838, ENSAPLP00000010639, ENSAPLP00000002838 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000011204, ENSAPLP00000013412, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000000450, ENSAPLP00000015416, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| protein transport | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000015416, ENSAPLP00000015838 |
| regulation of cell migration | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| regulation of locomotion | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000013090 |
| regulation of cellular response to stress | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000014519 |
| regulation of cell motility | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| blood vessel development | ENSAPLP00000007227, ENSAPLP00000002381 |
| vasculature development | ENSAPLP00000007227, ENSAPLP00000002381 |
| fatty acid metabolic process | ENSAPLP00000007174, ENSAPLP00000015838 |
| response to oxidative stress | ENSAPLP00000007174, ENSAPLP00000003219 |
| embryo development ending in birth or egg hatching | ENSAPLP00000015416, ENSAPLP00000003219 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of stress-activated MAPK cascade | ENSAPLP00000007355, ENSAPLP00000014519 |
| growth | ENSAPLP00000015416, ENSAPLP00000003657 |
| chordate embryonic development | ENSAPLP00000015416, ENSAPLP00000003219 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of stress-activated protein kinase signaling cascade | ENSAPLP00000007355, ENSAPLP00000014519 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000002381 |
| protein localization | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000014519 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828, ENSAPLP00000004050, ENSAPLP00000014519 |
| RNA splicing, via transesterification reactions | ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| mRNA splicing, via spliceosome | ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| regulation of cellular component movement | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| regulation of multicellular organismal process | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000013090, ENSAPLP00000014519 |
| small GTPase mediated signal transduction | ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000002305, ENSAPLP00000014519 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000013090 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| cell projection assembly | ENSAPLP00000007227, ENSAPLP00000006558 |
| regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| apoptotic process | ENSAPLP00000003657, ENSAPLP00000002381, ENSAPLP00000011273 |
| programmed cell death | ENSAPLP00000003657, ENSAPLP00000002381, ENSAPLP00000011273 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000014698, ENSAPLP00000014519, ENSAPLP00000002381 |
| RNA splicing | ENSAPLP00000011160, ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000006558, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| antigen processing and presentation of exogenous peptide antigen | ENSAPLP00000015838, ENSAPLP00000008799 |
| immune response | ENSAPLP00000015838, ENSAPLP00000015888 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000000450 |
| antigen processing and presentation of exogenous antigen | ENSAPLP00000015838, ENSAPLP00000008799 |
| regulation of cell morphogenesis | ENSAPLP00000013090, ENSAPLP00000014519 |
| regulation of actin filament length | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of multi-organism process | ENSAPLP00000015264, ENSAPLP00000008799 |
| cell death | ENSAPLP00000003657, ENSAPLP00000002381, ENSAPLP00000011273 |
| death | ENSAPLP00000003657, ENSAPLP00000002381, ENSAPLP00000011273 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| cell projection organization | ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000006558, ENSAPLP00000013090 |
| regulation of response to stress | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000008799, ENSAPLP00000014519 |
| regulation of cytokine production | ENSAPLP00000015838, ENSAPLP00000004050 |
| regulation of nucleoside metabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| antigen processing and presentation | ENSAPLP00000015838, ENSAPLP00000008799 |
| regulation of nucleotide catabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| monocarboxylic acid metabolic process | ENSAPLP00000007174, ENSAPLP00000015838 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of purine nucleotide catabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| antigen processing and presentation of peptide antigen | ENSAPLP00000015838, ENSAPLP00000008799 |
| epithelium development | ENSAPLP00000015416, ENSAPLP00000008503 |
| regulation of cellular component organization | ENSAPLP00000013412, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000013090, ENSAPLP00000014519 |
| cellular membrane organization | ENSAPLP00000015416, ENSAPLP00000008799, ENSAPLP00000013090 |
| membrane organization | ENSAPLP00000015416, ENSAPLP00000008799, ENSAPLP00000013090 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000003219, ENSAPLP00000014698, ENSAPLP00000014519, ENSAPLP00000002381 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002381, ENSAPLP00000014519 |
| cell development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000013090, ENSAPLP00000002381 |
| organic substance transport | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000015416, ENSAPLP00000015838 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519, ENSAPLP00000002381 |
| macromolecule localization | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000014519 |
| response to inorganic substance | ENSAPLP00000003657, ENSAPLP00000007174 |
| regulation of cellular component size | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of MAPK cascade | ENSAPLP00000015838, ENSAPLP00000007355 |
| negative regulation of cell differentiation | ENSAPLP00000015838, ENSAPLP00000000450 |
| regulation of secretion | ENSAPLP00000015838, ENSAPLP00000002046 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000002046, ENSAPLP00000004050 |
| positive regulation of intracellular protein kinase cascade | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828 |
| cell adhesion | ENSAPLP00000011833, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000003289 |
| biological adhesion | ENSAPLP00000011833, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000003289 |
| regulation of signaling | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000007227, ENSAPLP00000013414, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000014519 |
| regulation of nucleotide metabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| regulation of cellular catabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| regulation of I-kappaB kinase/NF-kappaB cascade | ENSAPLP00000015828, ENSAPLP00000004050 |
| regulation of purine nucleotide metabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000000450 |
| regulation of MAPK cascade | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000014519 |
| single-organism process | ENSAPLP00000015264, ENSAPLP00000009485, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000011204, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000011711, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000011273, ENSAPLP00000015416, ENSAPLP00000013414, ENSAPLP00000015562, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000002305, ENSAPLP00000014519, ENSAPLP00000007227, ENSAPLP00000013787, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000011303, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000007174, ENSAPLP00000002553, ENSAPLP00000003289, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000011833, ENSAPLP00000013412, ENSAPLP00000013090, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000014698 |
| intracellular signal transduction | ENSAPLP00000006040, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000002046, ENSAPLP00000002305, ENSAPLP00000014519 |
| response to stimulus | ENSAPLP00000015264, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000007174, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000015804, ENSAPLP00000015888, ENSAPLP00000013090, ENSAPLP00000015838, ENSAPLP00000013414, ENSAPLP00000006040, ENSAPLP00000003219, ENSAPLP00000002305, ENSAPLP00000014519 |
| cellular protein localization | ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000014519 |
| cellular macromolecule localization | ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000014519 |
| intracellular protein transport | ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090 |
| regulation of multicellular organismal development | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000014519 |
| cellular lipid metabolic process | ENSAPLP00000007174, ENSAPLP00000015838 |
| negative regulation of developmental process | ENSAPLP00000015838, ENSAPLP00000000450 |
| regulation of phosphate metabolic process | ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000014519 |
| regulation of phosphorus metabolic process | ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000014519 |
| localization | ENSAPLP00000007227, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000004050, ENSAPLP00000015251, ENSAPLP00000007174, ENSAPLP00000013412, ENSAPLP00000011711, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000015562, ENSAPLP00000014519 |
| regulation of cell differentiation | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000014519 |
| DNA metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000016262 |
| mRNA processing | ENSAPLP00000011160, ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| cell migration | ENSAPLP00000007227, ENSAPLP00000004050 |
| regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| establishment of localization | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000011711, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000007174, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000015562, ENSAPLP00000014519 |
| cellular response to stimulus | ENSAPLP00000015264, ENSAPLP00000013412, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000003219, ENSAPLP00000002305, ENSAPLP00000014519 |
| embryo development | ENSAPLP00000015416, ENSAPLP00000003219 |
| chromatin modification | ENSAPLP00000011204, ENSAPLP00000000450 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000013090, ENSAPLP00000014519 |
| cell motility | ENSAPLP00000007227, ENSAPLP00000004050 |
| regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| localization of cell | ENSAPLP00000007227, ENSAPLP00000004050 |
| positive regulation of metabolic process | ENSAPLP00000015264, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000014519 |
| regulation of immune system process | ENSAPLP00000015838, ENSAPLP00000008799, ENSAPLP00000000450 |
| positive regulation of protein metabolic process | ENSAPLP00000015838, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000014519 |
| regulation of cell communication | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000007227, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000014519 |
| positive regulation of biological process | ENSAPLP00000015264, ENSAPLP00000007355, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000015828, ENSAPLP00000003219, ENSAPLP00000014519 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000007174, ENSAPLP00000003219 |
| transcription, DNA-dependent | ENSAPLP00000015264, ENSAPLP00000005466 |
| chemotaxis | ENSAPLP00000004050, ENSAPLP00000013090 |
| taxis | ENSAPLP00000004050, ENSAPLP00000013090 |
| negative regulation of apoptotic process | ENSAPLP00000015838, ENSAPLP00000004050 |
| regulation of cellular component biogenesis | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of developmental process | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000013090, ENSAPLP00000014519 |
| cell communication | ENSAPLP00000013412, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000015562, ENSAPLP00000002305, ENSAPLP00000014519 |
| regulation of signal transduction | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000007227, ENSAPLP00000015828, ENSAPLP00000004050, ENSAPLP00000014519 |
| positive regulation of protein modification process | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000014519 |
| locomotion | ENSAPLP00000007227, ENSAPLP00000004050, ENSAPLP00000013090 |
| regulation of phosphorylation | ENSAPLP00000015838, ENSAPLP00000007227, ENSAPLP00000014519 |
| protein ubiquitination | ENSAPLP00000013414, ENSAPLP00000010371 |
| negative regulation of programmed cell death | ENSAPLP00000015838, ENSAPLP00000004050 |
| positive regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000000450 |
| negative regulation of cell death | ENSAPLP00000015838, ENSAPLP00000004050 |
| signal transduction | ENSAPLP00000013412, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000002305, ENSAPLP00000014519 |
| cellular component organization | ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000011204, ENSAPLP00000013412, ENSAPLP00000000450, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519 |
| organic acid metabolic process | ENSAPLP00000007174, ENSAPLP00000005342, ENSAPLP00000015838 |
| carboxylic acid metabolic process | ENSAPLP00000007174, ENSAPLP00000005342, ENSAPLP00000015838 |
| oxoacid metabolic process | ENSAPLP00000007174, ENSAPLP00000005342, ENSAPLP00000015838 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000015416, ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000014519 |
| positive regulation of protein phosphorylation | ENSAPLP00000015838, ENSAPLP00000014519 |
| regulation of catabolic process | ENSAPLP00000015416, ENSAPLP00000003219 |
| protein modification by small protein conjugation | ENSAPLP00000013414, ENSAPLP00000010371 |
| regulation of response to stimulus | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000007227, ENSAPLP00000015828, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000014519 |
| transport | ENSAPLP00000009485, ENSAPLP00000013412, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000007505, ENSAPLP00000011711, ENSAPLP00000013090, ENSAPLP00000015251, ENSAPLP00000007174, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000015562 |
| single-organism cellular process | ENSAPLP00000015264, ENSAPLP00000009485, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000011204, ENSAPLP00000014857, ENSAPLP00000015804, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000011273, ENSAPLP00000015416, ENSAPLP00000013414, ENSAPLP00000015562, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000002305, ENSAPLP00000014519, ENSAPLP00000007227, ENSAPLP00000013787, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000007174, ENSAPLP00000003289, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000011833, ENSAPLP00000013412, ENSAPLP00000013090, ENSAPLP00000015838, ENSAPLP00000006040 |
| cell part morphogenesis | ENSAPLP00000006558, ENSAPLP00000013090 |
| positive regulation of phosphorylation | ENSAPLP00000015838, ENSAPLP00000014519 |
| cell projection morphogenesis | ENSAPLP00000006558, ENSAPLP00000013090 |
| signaling | ENSAPLP00000013412, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000002305, ENSAPLP00000014519 |
| single organism signaling | ENSAPLP00000013412, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000002305, ENSAPLP00000014519 |
| regulation of localization | ENSAPLP00000015838, ENSAPLP00000013412, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000014519 |
| positive regulation of transcription from RNA polymerase II promoter | ENSAPLP00000002046, ENSAPLP00000000450 |
| oxidation-reduction process | ENSAPLP00000013577, ENSAPLP00000011273 |
| positive regulation of signal transduction | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828 |
| positive regulation of cell communication | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828 |
| positive regulation of signaling | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000014519 |
| positive regulation of macromolecule biosynthetic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450 |
| positive regulation of cellular process | ENSAPLP00000015264, ENSAPLP00000007355, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000015828, ENSAPLP00000003219, ENSAPLP00000014519 |
| cell morphogenesis | ENSAPLP00000006558, ENSAPLP00000013090 |
| chromatin organization | ENSAPLP00000011204, ENSAPLP00000000450 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000015838, ENSAPLP00000014519 |
| positive regulation of phosphate metabolic process | ENSAPLP00000015838, ENSAPLP00000014519 |
| cellular component organization or biogenesis | ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000011204, ENSAPLP00000013412, ENSAPLP00000000450, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000008503, ENSAPLP00000003219, ENSAPLP00000014519 |
| protein modification by small protein conjugation or removal | ENSAPLP00000013414, ENSAPLP00000010371 |
| intracellular transport | ENSAPLP00000015416, ENSAPLP00000007174, ENSAPLP00000015838, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090 |
| positive regulation of cellular biosynthetic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450 |
| regulation of transcription from RNA polymerase II promoter | ENSAPLP00000002553, ENSAPLP00000002046, ENSAPLP00000000450 |
| regulation of cell death | ENSAPLP00000015838, ENSAPLP00000015828, ENSAPLP00000004050 |
| vesicle-mediated transport | ENSAPLP00000015416, ENSAPLP00000002046, ENSAPLP00000008799 |
| regulation of protein modification process | ENSAPLP00000015838, ENSAPLP00000000450, ENSAPLP00000014519 |
| regulation of apoptotic process | ENSAPLP00000015838, ENSAPLP00000015828, ENSAPLP00000004050 |
| regulation of programmed cell death | ENSAPLP00000015838, ENSAPLP00000015828, ENSAPLP00000004050 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000003522, ENSAPLP00000014519 |
| positive regulation of biosynthetic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450 |
| positive regulation of cellular metabolic process | ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000000450, ENSAPLP00000014519 |
| nervous system development | ENSAPLP00000015416, ENSAPLP00000013090, ENSAPLP00000014519 |
| positive regulation of gene expression | ENSAPLP00000015416, ENSAPLP00000002046, ENSAPLP00000000450 |
| regulation of transport | ENSAPLP00000015838, ENSAPLP00000013412, ENSAPLP00000002046 |
| cellular localization | ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090, ENSAPLP00000007174, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000014519 |
| regulation of protein phosphorylation | ENSAPLP00000015838, ENSAPLP00000014519 |
| carbohydrate metabolic process | ENSAPLP00000003522, ENSAPLP00000013577 |
| response to DNA damage stimulus | ENSAPLP00000015264, ENSAPLP00000002046 |
| positive regulation of response to stimulus | ENSAPLP00000015838, ENSAPLP00000007355, ENSAPLP00000015828 |
| regulation of biological quality | ENSAPLP00000010639, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000013090, ENSAPLP00000002381 |
| RNA processing | ENSAPLP00000011160, ENSAPLP00000015264, ENSAPLP00000012941, ENSAPLP00000011868 |
| establishment of localization in cell | ENSAPLP00000015416, ENSAPLP00000007174, ENSAPLP00000015838, ENSAPLP00000009485, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000013090 |
| nucleic acid metabolic process | ENSAPLP00000011160, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000016262, ENSAPLP00000012941 |
| protein targeting to membrane | ENSAPLP00000015416, ENSAPLP00000013090 |
| regulation of hydrolase activity | ENSAPLP00000015416, ENSAPLP00000003219 |
| immune system process | ENSAPLP00000015838, ENSAPLP00000015888, ENSAPLP00000008799 |
| positive regulation of RNA metabolic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000000450 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000007174, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000013090 |
| regulation of protein metabolic process | ENSAPLP00000015838, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000014519 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000015838, ENSAPLP00000008503, ENSAPLP00000004377, ENSAPLP00000002381 |
| single-organism transport | ENSAPLP00000015416, ENSAPLP00000007174, ENSAPLP00000015562, ENSAPLP00000002046, ENSAPLP00000011303, ENSAPLP00000008799, ENSAPLP00000011711, ENSAPLP00000013090 |
| protein targeting | ENSAPLP00000015416, ENSAPLP00000002046, ENSAPLP00000013090 |
| neurogenesis | ENSAPLP00000013090, ENSAPLP00000014519 |
| generation of neurons | ENSAPLP00000013090, ENSAPLP00000014519 |
| chromosome organization | ENSAPLP00000011204, ENSAPLP00000000450 |
| regulation of cellular process | ENSAPLP00000015264, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000002553, ENSAPLP00000011204, ENSAPLP00000007355, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000015804, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000006040, ENSAPLP00000015828, ENSAPLP00000003219, ENSAPLP00000002305, ENSAPLP00000014519 |
| regulation of cellular metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000015828, ENSAPLP00000014519 |
| regulation of cellular protein metabolic process | ENSAPLP00000015838, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000014519 |
| biological regulation | ENSAPLP00000015264, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000002553, ENSAPLP00000010639, ENSAPLP00000002381, ENSAPLP00000011204, ENSAPLP00000007355, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000015804, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000006040, ENSAPLP00000013414, ENSAPLP00000003219, ENSAPLP00000015828, ENSAPLP00000002305, ENSAPLP00000014519 |
| cellular component assembly | ENSAPLP00000015838, ENSAPLP00000011204, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008503, ENSAPLP00000004377 |
| cellular response to stress | ENSAPLP00000015264, ENSAPLP00000003219, ENSAPLP00000002046 |
| regulation of primary metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000015828, ENSAPLP00000014519 |
| response to stress | ENSAPLP00000007174, ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000002046, ENSAPLP00000004050 |
| protein complex assembly | ENSAPLP00000015838, ENSAPLP00000004377 |
| proteolysis | ENSAPLP00000013414, ENSAPLP00000002532, ENSAPLP00000015251 |
| positive regulation of nucleobase-containing compound metabolic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000000450 |
| RNA metabolic process | ENSAPLP00000011160, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000005466, ENSAPLP00000009447, ENSAPLP00000012941, ENSAPLP00000011868 |
| negative regulation of cellular process | ENSAPLP00000011204, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| mRNA metabolic process | ENSAPLP00000011160, ENSAPLP00000015264, ENSAPLP00000009447, ENSAPLP00000012941, ENSAPLP00000011868 |
| cellular macromolecular complex assembly | ENSAPLP00000011204, ENSAPLP00000004377 |
| protein complex biogenesis | ENSAPLP00000015838, ENSAPLP00000004377 |
| cellular process | ENSAPLP00000015264, ENSAPLP00000009485, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000010371, ENSAPLP00000011868, ENSAPLP00000010639, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000015804, ENSAPLP00000014857, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000011273, ENSAPLP00000015416, ENSAPLP00000005466, ENSAPLP00000003522, ENSAPLP00000013414, ENSAPLP00000015562, ENSAPLP00000003219, ENSAPLP00000008503, ENSAPLP00000013577, ENSAPLP00000002305, ENSAPLP00000014519, ENSAPLP00000012941, ENSAPLP00000005342, ENSAPLP00000007227, ENSAPLP00000013787, ENSAPLP00000004377, ENSAPLP00000008799, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000015251, ENSAPLP00000007174, ENSAPLP00000003289, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000011833, ENSAPLP00000013412, ENSAPLP00000013090, ENSAPLP00000015838, ENSAPLP00000006040, ENSAPLP00000016262 |
| positive regulation of molecular function | ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000015828 |
| negative regulation of cellular biosynthetic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| positive regulation of transcription, DNA-dependent | ENSAPLP00000002046, ENSAPLP00000000450 |
| negative regulation of cellular macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| regulation of biological process | ENSAPLP00000015264, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000002046, ENSAPLP00000008799, ENSAPLP00000004050, ENSAPLP00000002553, ENSAPLP00000011204, ENSAPLP00000007355, ENSAPLP00000013412, ENSAPLP00000014857, ENSAPLP00000015804, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000013090, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000006040, ENSAPLP00000015828, ENSAPLP00000003219, ENSAPLP00000002305, ENSAPLP00000014519 |
| cell surface receptor signaling pathway | ENSAPLP00000015838, ENSAPLP00000013414, ENSAPLP00000015804, ENSAPLP00000006558 |
| positive regulation of nitrogen compound metabolic process | ENSAPLP00000015264, ENSAPLP00000002046, ENSAPLP00000000450 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000002838, ENSAPLP00000011273, ENSAPLP00000007174, ENSAPLP00000010639, ENSAPLP00000015838, ENSAPLP00000013577, ENSAPLP00000014519 |
| negative regulation of macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015828 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| negative regulation of biosynthetic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| negative regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000009447 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| regulation of transcription, DNA-dependent | ENSAPLP00000002553, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000000450 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000015838, ENSAPLP00000011204, ENSAPLP00000008503, ENSAPLP00000004377, ENSAPLP00000002381 |
| regulation of cellular biosynthetic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015828 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| positive regulation of catalytic activity | ENSAPLP00000007227, ENSAPLP00000003219 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| regulation of RNA biosynthetic process | ENSAPLP00000002553, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000000450 |
| negative regulation of biological process | ENSAPLP00000011204, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000014519 |
| cellular response to chemical stimulus | ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of biosynthetic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015828 |
| macromolecular complex assembly | ENSAPLP00000015838, ENSAPLP00000011204, ENSAPLP00000004377 |
| nucleobase-containing compound metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000009447, ENSAPLP00000000450 |
| RNA biosynthetic process | ENSAPLP00000015264, ENSAPLP00000005466 |
| organic cyclic compound metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000010639, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015828, ENSAPLP00000003219 |
| regulation of metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000007227, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000003219, ENSAPLP00000015828, ENSAPLP00000014519 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000003522, ENSAPLP00000014519 |
| multi-organism reproductive process | ENSAPLP00000015416, ENSAPLP00000008799 |
| cellular component biogenesis | ENSAPLP00000015838, ENSAPLP00000011204, ENSAPLP00000007227, ENSAPLP00000006558, ENSAPLP00000008503, ENSAPLP00000004377 |
| regulation of catalytic activity | ENSAPLP00000015416, ENSAPLP00000007227, ENSAPLP00000003219 |
| regulation of macromolecule metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000004050, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015838, ENSAPLP00000015828, ENSAPLP00000014519 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| regulation of cell proliferation | ENSAPLP00000015838, ENSAPLP00000011204 |
| cellular response to organic substance | ENSAPLP00000015838, ENSAPLP00000004050 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000015838, ENSAPLP00000004050 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| cellular aromatic compound metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| regulation of molecular function | ENSAPLP00000015416, ENSAPLP00000007227, ENSAPLP00000003219, ENSAPLP00000015828 |
| heterocycle metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015828, ENSAPLP00000003219 |
| multi-organism process | ENSAPLP00000015416, ENSAPLP00000008799, ENSAPLP00000002381 |
| regulation of RNA metabolic process | ENSAPLP00000002553, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000015828, ENSAPLP00000002046, ENSAPLP00000000450 |
| regulation of gene expression | ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002046, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000002553, ENSAPLP00000015416, ENSAPLP00000015828 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000013577, ENSAPLP00000014519 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| cellular nitrogen compound metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000007174, ENSAPLP00000005342, ENSAPLP00000015838, ENSAPLP00000013577, ENSAPLP00000014519 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000014519 |
| negative regulation of cellular metabolic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| nitrogen compound metabolic process | ENSAPLP00000011160, ENSAPLP00000003657, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000009447, ENSAPLP00000011868, ENSAPLP00000005466, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| organic cyclic compound biosynthetic process | ENSAPLP00000015264, ENSAPLP00000010639, ENSAPLP00000005466 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000013577, ENSAPLP00000009447, ENSAPLP00000014519, ENSAPLP00000015251 |
| reproductive process | ENSAPLP00000015416, ENSAPLP00000008799 |
| macromolecule biosynthetic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000005466 |
| cellular macromolecule biosynthetic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000005466 |
| cellular protein modification process | ENSAPLP00000013414, ENSAPLP00000010371, ENSAPLP00000000450 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009447, ENSAPLP00000014519 |
| protein modification process | ENSAPLP00000013414, ENSAPLP00000010371, ENSAPLP00000000450 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009447, ENSAPLP00000014519 |
| gene expression | ENSAPLP00000011160, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000005466, ENSAPLP00000012941, ENSAPLP00000011868 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| negative regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000009447 |
| macromolecule modification | ENSAPLP00000013414, ENSAPLP00000010371, ENSAPLP00000000450 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009447, ENSAPLP00000014519 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000009447, ENSAPLP00000014519 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000009447, ENSAPLP00000014519 |
| reproduction | ENSAPLP00000015416, ENSAPLP00000008799 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000015264, ENSAPLP00000005466 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000013577, ENSAPLP00000009447, ENSAPLP00000014519 |
| cellular biosynthetic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000010639, ENSAPLP00000011204, ENSAPLP00000005466 |
| aromatic compound biosynthetic process | ENSAPLP00000015264, ENSAPLP00000005466 |
| macromolecule metabolic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000010371, ENSAPLP00000015251, ENSAPLP00000011868, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000015838, ENSAPLP00000013414, ENSAPLP00000005466, ENSAPLP00000002532, ENSAPLP00000016262, ENSAPLP00000012941 |
| heterocycle biosynthetic process | ENSAPLP00000015264, ENSAPLP00000005466 |
| cellular macromolecule catabolic process | ENSAPLP00000013414, ENSAPLP00000009447 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000015264, ENSAPLP00000005466 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000013577, ENSAPLP00000014519 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000013414, ENSAPLP00000009447, ENSAPLP00000014519, ENSAPLP00000015251 |
| organic substance biosynthetic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000010639, ENSAPLP00000011204, ENSAPLP00000005466 |
| primary metabolic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000010371, ENSAPLP00000002838, ENSAPLP00000015251, ENSAPLP00000011868, ENSAPLP00000007174, ENSAPLP00000010639, ENSAPLP00000003657, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000002532, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| biosynthetic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000015838, ENSAPLP00000010639, ENSAPLP00000011204, ENSAPLP00000005466 |
| macromolecule catabolic process | ENSAPLP00000013414, ENSAPLP00000009447 |
| cellular macromolecule metabolic process | ENSAPLP00000011160, ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000010371, ENSAPLP00000009447, ENSAPLP00000000450, ENSAPLP00000011868, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000016262, ENSAPLP00000012941 |
| organic substance metabolic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000010371, ENSAPLP00000002838, ENSAPLP00000015251, ENSAPLP00000011868, ENSAPLP00000007174, ENSAPLP00000010639, ENSAPLP00000003657, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000002532, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| metabolic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000010371, ENSAPLP00000002838, ENSAPLP00000015251, ENSAPLP00000011868, ENSAPLP00000007174, ENSAPLP00000010639, ENSAPLP00000003657, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000011273, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000002532, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| cellular metabolic process | ENSAPLP00000005342, ENSAPLP00000015264, ENSAPLP00000010371, ENSAPLP00000015251, ENSAPLP00000011868, ENSAPLP00000007174, ENSAPLP00000010639, ENSAPLP00000003657, ENSAPLP00000011160, ENSAPLP00000011204, ENSAPLP00000002560, ENSAPLP00000000450, ENSAPLP00000009447, ENSAPLP00000015838, ENSAPLP00000005466, ENSAPLP00000013414, ENSAPLP00000003522, ENSAPLP00000013577, ENSAPLP00000016262, ENSAPLP00000014519, ENSAPLP00000012941 |
| protein metabolic process | ENSAPLP00000005342, ENSAPLP00000015838, ENSAPLP00000013414, ENSAPLP00000002532, ENSAPLP00000010371, ENSAPLP00000000450, ENSAPLP00000015251 |
| cellular protein metabolic process | ENSAPLP00000005342, ENSAPLP00000015838, ENSAPLP00000013414, ENSAPLP00000010371, ENSAPLP00000000450 |
|